- Home
- QSR vs BIIB Comparison
QSR vs BIIB Comparison
Compare QSR & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSR
- BIIB
- Stock Information
- Founded
- QSR 1954
- BIIB 1978
- Country
- QSR Canada
- BIIB United States
- Employees
- QSR N/A
- BIIB N/A
- Industry
- QSR
- BIIB Biotechnology: Pharmaceutical Preparations
- Sector
- QSR
- BIIB Health Care
- Exchange
- QSR Nasdaq
- BIIB Nasdaq
- Market Cap
- QSR 22.3B
- BIIB 19.9B
- IPO Year
- QSR 2006
- BIIB 1991
- Fundamental
- Price
- QSR $67.84
- BIIB $130.71
- Analyst Decision
- QSR Buy
- BIIB Buy
- Analyst Count
- QSR 22
- BIIB 27
- Target Price
- QSR $79.93
- BIIB $220.50
- AVG Volume (30 Days)
- QSR 2.1M
- BIIB 1.8M
- Earning Date
- QSR 05-08-2025
- BIIB 04-23-2025
- Dividend Yield
- QSR 3.66%
- BIIB N/A
- EPS Growth
- QSR N/A
- BIIB 40.28
- EPS
- QSR 3.18
- BIIB 11.18
- Revenue
- QSR $8,406,000,000.00
- BIIB $9,675,900,000.00
- Revenue This Year
- QSR $10.11
- BIIB N/A
- Revenue Next Year
- QSR $3.57
- BIIB N/A
- P/E Ratio
- QSR $21.35
- BIIB $11.75
- Revenue Growth
- QSR 19.71
- BIIB N/A
- 52 Week Low
- QSR $59.67
- BIIB $128.51
- 52 Week High
- QSR $77.64
- BIIB $238.00
- Technical
- Relative Strength Index (RSI)
- QSR 54.82
- BIIB 32.01
- Support Level
- QSR $66.08
- BIIB $128.75
- Resistance Level
- QSR $67.54
- BIIB $144.07
- Average True Range (ATR)
- QSR 1.57
- BIIB 3.72
- MACD
- QSR -0.12
- BIIB -1.21
- Stochastic Oscillator
- QSR 73.14
- BIIB 11.38
About QSR Restaurant Brands International Inc.
Restaurant Brands International is one of the largest restaurant companies in the world, with approximately $44 billion in 2024 systemwide sales across a footprint that spanned more than 32,000 restaurants and more than 100 countries. The firm generates revenue primarily from retail sales at its company-owned restaurants, royalty fees and lease income from franchised stores, and from its Tim Hortons supply chain operations. Formed in 2014 after 3G Capital's acquisition of Tim Hortons International, the RBI portfolio is split among Burger King (7,082 units), Tim Hortons (4,539 units), Popeyes Louisiana Kitchen (3,520 units), Firehouse Subs (1,345 units), and international franchise units of those banners (15,639) as of year-end 2024.
About BIIB Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.